Breaking News: Embargoed Feed - hidden

Filters close
29-May-2024 9:00 AM EDT
Race and social vulnerability impact glycemic control in people with diabetes
Endocrine Society

People of color and those who experience social vulnerability are more likely to experience worse glycemic control than their white counterparts, according to research presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

29-May-2024 9:00 AM EDT
Higher blood concentrations of testosterone are associated with reduced risk of developing type 2 diabetes in men under 65
Endocrine Society

Testosterone appears protective against developing type 2 diabetes in men who are overweight or obese and under age 65, but not in men over that age, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

29-May-2024 9:05 AM EDT
Childhood stress linked with earlier substance use in male and female teens
Endocrine Society

Stress during childhood is associated with earlier substance use in male and female adolescents, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. Traumatic events may increase substance use risk for males, while environmental stress and early puberty may increase the risk for females, the researchers found.

29-May-2024 9:00 AM EDT
Insurance often denies GLP-1 medications for teens with type 2 diabetes, obesity
Endocrine Society

Health insurance companies often deny coverage for new medications that treat children and teens with obesity and type 2 diabetes, meaning many patients who need treatment are unable to afford it, according to a study presented at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

30-May-2024 12:05 PM EDT
Experimental Therapy Shows Promise in Pancreatic Cancer Clinical Trial
Lombardi Comprehensive Cancer Center at Georgetown University

Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled in a phase 2 clinical trial of the experimental drug BXCL701 in combination with the immunotherapy drug pembrolizumab (Keytruda).

31-May-2024 8:00 AM EDT
Detecting Machine-Written Content in Scientific Articles
University of Chicago Medical Center

University of Chicago researchers evaluated text from over 15,000 ASCO Annual Meeting abstracts from 2021 to 2023 and found that there were approximately twice as many abstracts containing AI content in 2023 compared to 2021 and 2022.

Newswise: Simulation Sessions Help ICU Clinicians Prepare for High-Risk, Infrequent Emergency Procedures
29-May-2024 12:05 PM EDT
Simulation Sessions Help ICU Clinicians Prepare for High-Risk, Infrequent Emergency Procedures
American Association of Critical-Care Nurses (AACN)

The cardiovascular ICU at the University of Mississippi Medical Center developed a simulation training program to improve clinicians’ ability to recognize clinical signs that would prompt an emergency ICU sternotomy for a postoperative cardiac surgery patient and rehearse the high-risk but infrequent procedure.

Query Closed
Reporter's Deadline Passed
12-May-2024 3:03 PM EDT
We are looking for news - Lubomir Straka, Editor in Chief - www.Techpedia.sk
Newswise Expert Queries

We are looking for news about all kinds of technologies, about research and development in

       
Query Closed
Reporter's Deadline Passed
20-May-2024 10:00 AM EDT
I am seeking guest columnists - Kerry Smith Buck, President and CEO
Newswise Expert Queries

I am seeking guest columnists on various engineering and construction topics. The expert-written guest

31-May-2024 8:00 AM EDT
ASCO: Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center presented positive clinical results from two studies today at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.

Not for public release

This news release is embargoed until 31-May-2024 11:00 AM EDT Released to reporters: 29-May-2024 1:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 31-May-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Researchers Identify a Genetic Cause of Intellectual Disability Affecting Tens of Thousands
28-May-2024 1:05 PM EDT
Researchers Identify a Genetic Cause of Intellectual Disability Affecting Tens of Thousands
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai and others have identified a neurodevelopmental disorder, caused by mutations in a single gene, that affects tens of thousands of people worldwide. The work, published in the May 31 online issue of Nature Medicine [DOI: 10.1038/s41591-024-03085-5], was done in collaboration with colleagues at the University of Bristol, UK; KU Leuven, Belgium; and the NIHR BioResource, currently based at the University of Cambridge, UK. The findings will improve clinical diagnostic services for patients with neurodevelopmental disorders.

23-May-2024 2:05 PM EDT
Violence, aggression against educators grew post-pandemic
American Psychological Association (APA)

While threats and violence against pre-K to 12th-grade teachers and other school personnel in the United States declined during the pandemic, after the restrictions were lifted, incidents rebounded to levels equal to or exceeding those prior to the pandemic, according to research published by the American Psychological Association.

Newswise: Dana-Farber researchers uncover disparities in lived experiences for patients and physicians
29-May-2024 8:05 AM EDT
Dana-Farber researchers uncover disparities in lived experiences for patients and physicians
Dana-Farber Cancer Institute

Four teams of Dana-Farber Cancer Institute investigators have found that people experience discrimination and bias in different ways and in more realms of cancer care than previously understood. The findings, in different studies, suggest that oncology professionals and the systems they work in have more work to do to adapt to the realities of increasing diversity and inclusion, not only in the patient population but also in the oncology workforce.

29-May-2024 3:05 PM EDT
Risk of death from COVID-19 lessens, but infection still can cause issues 3 years later
Washington University in St. Louis

New findings on long COVID by Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care system reveal that COVID-19 patients who were hospitalized within the first 30 days after infection face a 29% higher risk of death in the third year post-infection compared with people who have not had the virus.

29-May-2024 8:05 AM EDT
Structural Inequities Amplify Homelessness Challenges for Pregnant People in Washington DC
Georgetown University Medical Center

New research conducted with Washington, DC, residents who experienced homelessness during pregnancy sheds light on the intersection of homelessness, pregnancy, and racial inequities. The findings underscore the urgent need for policy and practice changes to support vulnerable populations.

23-May-2024 4:00 PM EDT
Do Epilepsy Medications Taken During Pregnancy Affect a Child’s Creativity?
American Academy of Neurology (AAN)

While older drugs for epilepsy, taken while pregnant, have been shown in previous research to affect the creative thinking of children, a new study finds no effects on creativity for children born to those taking newer epilepsy drugs. This study is published in the May 29, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

23-May-2024 4:05 PM EDT
First Hints of Memory Problems Associated with Changes in the Brain
American Academy of Neurology (AAN)

People who report early memory problems and whose partners also suspect they have memory problems have higher levels of tau tangles in the brain, a biomarker associated with Alzheimer’s disease, according to a study published in the May 29, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

28-May-2024 2:05 PM EDT
Children often exposed to problematic click bait during YouTube searches
Michigan Medicine - University of Michigan

When a child peruses YouTube, the content recommended to them is not always age appropriate, a new study suggests.



close
8.92894